MAPK1 and polycystic ovary syndrome: In addition, in vivo experiments have shown that C. chinensis treatment can improve polycystic ovary syndrome by improving the quality of follicles and reversing ovarian histopathological damage, reducing the expression of cellular inflammation-related proteins (MAPK1, IL-6, CXCL8, and IL1B) in ovarian tissue.